2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast CancerHER2-positive Breast CancerRecruitingPhase 22026-09-11NCT05306041
Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vesselscardiovascular disorder, peripheral vascular disease, vascular disorderActive, not recruitingNot stated2026-04-14NCT03720704